Annual Working Capital
$78.28 M
-$159.23 M-67.04%
December 31, 2023
Summary
- As of February 12, 2025, DYN annual working capital is $78.28 million, with the most recent change of -$159.23 million (-67.04%) on December 31, 2023.
- During the last 3 years, DYN annual working capital has fallen by -$259.84 million (-76.85%).
- DYN annual working capital is now -77.87% below its all-time high of $353.67 million, reached on December 31, 2021.
Performance
DYN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$693.13 M
-$69.44 M-9.11%
September 30, 2024
Summary
- As of February 12, 2025, DYN quarterly working capital is $693.13 million, with the most recent change of -$69.44 million (-9.11%) on September 30, 2024.
- Over the past year, DYN quarterly working capital has dropped by -$69.44 million (-9.11%).
- DYN quarterly working capital is now -9.11% below its all-time high of $762.57 million, reached on June 30, 2024.
Performance
DYN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DYN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.0% | -9.1% |
| 3 y3 years | -76.8% | +259.2% |
| 5 y5 years | +951.2% | +259.2% |
DYN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.9% | at low | -9.1% | +785.5% |
| 5 y | 5-year | -77.9% | +531.2% | -9.1% | +5489.3% |
| alltime | all time | -77.9% | +951.2% | -9.1% | +5489.3% |
Dyne Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $693.13 M(-9.1%) |
| Jun 2024 | - | $762.57 M(+63.7%) |
| Mar 2024 | - | $465.78 M(+495.0%) |
| Dec 2023 | $78.28 M(-67.0%) | $78.28 M(-43.5%) |
| Sep 2023 | - | $138.52 M(-28.2%) |
| Jun 2023 | - | $192.95 M(-15.2%) |
| Mar 2023 | - | $227.63 M(-4.2%) |
| Dec 2022 | $237.51 M | $237.51 M(+1.1%) |
| Sep 2022 | - | $234.91 M(-13.7%) |
| Jun 2022 | - | $272.31 M(-15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $321.21 M(-9.2%) |
| Dec 2021 | $353.67 M(+4.6%) | $353.67 M(-11.9%) |
| Sep 2021 | - | $401.30 M(-10.2%) |
| Jun 2021 | - | $446.75 M(-5.7%) |
| Mar 2021 | - | $473.62 M(+40.1%) |
| Dec 2020 | $338.12 M(+2626.6%) | $338.12 M(-9.9%) |
| Sep 2020 | - | $375.16 M(+166.2%) |
| Jun 2020 | - | $140.95 M(+1036.6%) |
| Dec 2019 | $12.40 M(+66.5%) | $12.40 M |
| Dec 2018 | $7.45 M | - |
FAQ
- What is Dyne Therapeutics annual working capital?
- What is the all time high annual working capital for Dyne Therapeutics?
- What is Dyne Therapeutics annual working capital year-on-year change?
- What is Dyne Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly working capital year-on-year change?
What is Dyne Therapeutics annual working capital?
The current annual working capital of DYN is $78.28 M
What is the all time high annual working capital for Dyne Therapeutics?
Dyne Therapeutics all-time high annual working capital is $353.67 M
What is Dyne Therapeutics annual working capital year-on-year change?
Over the past year, DYN annual working capital has changed by -$159.23 M (-67.04%)
What is Dyne Therapeutics quarterly working capital?
The current quarterly working capital of DYN is $693.13 M
What is the all time high quarterly working capital for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly working capital is $762.57 M
What is Dyne Therapeutics quarterly working capital year-on-year change?
Over the past year, DYN quarterly working capital has changed by -$69.44 M (-9.11%)